PeerView Kidney & Genitourinary Diseases CME/CNE/CPE Video Podcast
by PVI, PeerView Institute for Medical Education
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·82 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 16 epsHost
Recent guests
Recent episodes
Philip J. Mease, MD, MACR - Breaking the Burden of Systemic Lupus Erythematosus: Patient Testimonials and Interprofessional Perspectives on New Developments With CAR-T Cell Therapy
Jul 13, 2026
53m 04s
Matthew D. Galsky, MD - Bladder Cancer Breakthroughs Unpacked: Practical Guidance on Bladder-Sparing Innovations, Perioperative Standards, and Multi-Targeted Platforms Across the Disease Spectrum
Jul 8, 2026
1h 26m 52s
Kalpana Gupta, MD, MPH, Anthony J. Schaeffer, MD - Breaking Barriers in cUTI Care: Integrating Novel Oral Therapies and Transitions of Care
Jul 8, 2026
1h 00m 42s
Andrew J. Armstrong, MD, ScM, FACP - Continuing the Innovation Story in Prostate Cancer: Novel Advances and Therapeutic Expansions Across Disease Settings
Jul 8, 2026
1h 26m 47s
Fred Saad, CQ, MD, FRCS, FCAHS - Next-Generation Treatment Pathways in Prostate Cancer: Practical Case-Driven Guidance to Individualize Care
Jul 8, 2026
1h 00m 39s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/13/26 | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Philip J. Mease, MD, MACR | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Alnylam Pharmaceuticals, Inc. | 53m 04s | ||
| 7/8/26 | bladder cancerhealthcare innovations+4 | Matthew D. Galsky, MD | PVI, PeerView Institute for Medical EducationWorld Bladder Cancer Patient Coalition | Rahway, NJ, USA | bladder cancerCME+4 | Astellas | 1h 26m 52s | ||
| 7/8/26 | cUTI carenovel oral therapies+3 | Kalpana Gupta, MD, MPHAnthony J. Schaeffer, MD | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | cUTIoral therapies+3 | GSK | 1h 00m 42s | ||
| 7/8/26 | prostate cancertherapeutic advances+3 | Andrew J. Armstrong, MD, ScM, FACP | PVI, PeerView Institute for Medical EducationThe Prostate Net+3 | — | prostate cancerCME+3 | Bayer HealthCare Pharmaceuticals Inc. | 1h 26m 47s | ||
| 7/8/26 | prostate cancertreatment pathways+3 | Fred Saad | PVI, PeerView Institute for Medical EducationZERO Prostate Cancer+3 | — | prostate cancertreatment pathways+5 | Bayer HealthCare Pharmaceuticals Inc. | 1h 00m 39s | ||
| 5/25/26 | IgA NephropathyStandards of Care+3 | Gerald Appel, MDEllie Kelepouris, MD, FACP, FAHA | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | IgA NephropathyCME+3 | Novartis Pharmaceuticals Corporation | 1h 02m 27s | ||
| 5/7/26 | Incretin-based therapiesType 2 diabetes+3 | Jay H. Shubrook, DO, FAAFP, FACOFP | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | incretinType 2 diabetes+3 | Lilly | 1h 25m 04s | ||
| 2/4/26 | targeted therapyextrapulmonary neuroendocrine carcinomas+3 | Jaume Capdevila, MD, PhD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | neuroendocrine carcinomastargeted therapy+3 | Boehringer Ingelheim Pharmaceuticals, Inc. | 32m 56s | ||
| 1/13/26 | mHSPCprecision therapies+3 | Noel Clarke, MBBS, FRCS ChMJoaquin Mateo, MD, PhD+1 | PVI, PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education (ACCME)+2 | — | mHSPCprecision medicine+3 | AstraZeneca | 37m 39s | ||
| 1/13/26 | NMIBC CareIntravesical Therapies+3 | Sia Daneshmand, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | NMIBCIntravesical Therapy+3 | Johnson & Johnson | 26m 30s | ||
| 1/9/26 | prostate cancergenomics+3 | Fred Saad | PVI, PeerView Institute for Medical EducationZERO Prostate Cancer+3 | — | prostate cancergenomics+3 | Astellas | 1h 01m 51s | ||
| 12/3/25 | ADCs in Gynecologic CancersHealthcare Education+3 | Susana BanerjeeKathleen N. Moore | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | ADCsGynecologic Cancers+5 | AstraZeneca | 38m 01s | ||
| 6/24/25 | bladder cancerantibody-drug conjugates+3 | Shilpa Gupta, MD | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | bladder cancerantibody-drug conjugates+5 | Astellas | 36m 05s | ||
| 6/23/25 | RCC treatmentindividualized patient care+3 | Sumanta Kumar Pal, MD, FASCO | PVI, PeerView Institute for Medical EducationKidney Cancer Research Alliance+3 | — | RCCtreatment innovations+3 | AVEO Pharmaceuticals, Inc. | 1h 26m 50s | ||
| 6/23/25 | prostate cancergenomics+3 | Karim Fizazi, MD, PhD | PVI, PeerView Institute for Medical EducationZERO Prostate Cancer+3 | — | prostate cancergenomics+4 | AstraZeneca | 1h 27m 03s | ||
| 6/11/25 | Systemic Lupus ErythematosusCAR-T Cell Therapy+3 | Anca D. Askanase, MD, MPHPhilip J. Mease, MD, MACR | PeerView Institute for Medical EducationAccreditation Council for Continuing Medical Education+2 | — | lupusCAR-T therapy+3 | Bristol Myers Squibb | 43m 05s |
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.